Glycosylation is a fundamental cellular process that, in eukaryotes, occurs in the lumen of both the Golgi apparatus and the endoplasmic reticulum1. Nucleotide sugar transporters (NSTs) are an essential component of the glycosylation pathway, providing the diverse range of substrates required for the glycosyltransferases2,3. NSTs are linked to several developmental and immune disorders in humans, and in pathogenic microbes they have an important role in virulence4,5,6,7,8. How NSTs recognize and transport activated monosaccharides, however, is currently unclear. Here we present the crystal structure of an NST, the GDP–mannose transporter Vrg4, in both the substrate-free and the bound states. A hitherto unobserved requirement of short-chain lipids in activating the transporter supports a model for regulation within the highly dynamic membranes of the Golgi apparatus. Our results provide a structural basis for understanding nucleotide sugar recognition, and provide insights into the transport and regulatory mechanism of this family of intracellular transporters.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. & Dwek, R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 343, 1235681 (2014)
Carey, D. J., Sommers, L. W. & Hirschberg, C. B. CMP-N-acetylneuraminic acid: isolation from and penetration into mouse liver microsomes. Cell 19, 597–605 (1980)
Hirschberg, C. B., Robbins, P. W. & Abeijon, C. Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu. Rev. Biochem. 67, 49–69 (1998)
Lühn, K., Wild, M. K., Eckhardt, M., Gerardy-Schahn, R. & Vestweber, D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat. Genet. 28, 69–72 (2001)
Martinez-Duncker, I. et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood 105, 2671–2676 (2005)
Descoteaux, A., Luo, Y., Turco, S. J. & Beverley, S. M. A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 269, 1869–1872 (1995)
Nishikawa, A., Poster, J. B., Jigami, Y. & Dean, N. Molecular and phenotypic analysis of CaVRG4, encoding an essential Golgi apparatus GDP-mannose transporter. J. Bacteriol. 184, 29–42 (2002)
Lübke, T. et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73–76 (2001)
Dunphy, W. G., Fries, E., Urbani, L. J. & Rothman, J. E. Early and late functions associated with the Golgi apparatus reside in distinct compartments. Proc. Natl Acad. Sci. USA 78, 7453–7457 (1981)
Ishida, N. & Kawakita, M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch. 447, 768–775 (2004)
Dean, N., Zhang, Y. B. & Poster, J. B. The VRG4 gene is required for GDP-mannose transport into the lumen of the Golgi in the yeast, Saccharomyces cerevisiae. J. Biol. Chem. 272, 31908–31914 (1997)
Haanstra, J. R., González-Marcano, E. B., Gualdrón-López, M. & Michels, P. A. Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites. Biochim. Biophys. Acta 1863, 1038–1048 (2016)
Liu, L., Xu, Y. X. & Hirschberg, C. B. The role of nucleotide sugar transporters in development of eukaryotes. Semin. Cell Dev. Biol. 21, 600–608 (2010)
Jack, D. L., Yang, N. M. & Saier, M. H. Jr. The drug/metabolite transporter superfamily. Eur. J. Biochem. 268, 3620–3639 (2001)
Tsuchiya, H. et al. Structural basis for amino acid export by DMT superfamily transporter YddG. Nature 534, 417–420 (2016)
Gao, X. D. & Dean, N. Distinct protein domains of the yeast Golgi GDP-mannose transporter mediate oligomer assembly and export from the endoplasmic reticulum. J. Biol. Chem. 275, 17718–17727 (2000)
Abe, M., Noda, Y., Adachi, H. & Yoda, K. Localization of GDP-mannose transporter in the Golgi requires retrieval to the endoplasmic reticulum depending on its cytoplasmic tail and coatomer. J. Cell Sci. 117, 5687–5696 (2004)
Capasso, J. M. & Hirschberg, C. B. Mechanisms of glycosylation and sulfation in the Golgi apparatus: evidence for nucleotide sugar/nucleoside monophosphate and nucleotide sulfate/nucleoside monophosphate antiports in the Golgi apparatus membrane. Proc. Natl Acad. Sci. USA 81, 7051–7055 (1984)
van Meer, G. Lipids of the Golgi membrane. Trends Cell Biol. 8, 29–33 (1998)
Parker, J. L., Mindell, J. A. & Newstead, S. Thermodynamic evidence for a dual transport mechanism in a POT peptide transporter. eLife 3, e04273 (2014)
Schmidt, D., Jiang, Q.-X. & MacKinnon, R. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature 444, 775–779 (2006)
van Meer, G., Voelker, D. R. & Feigenson, G. W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112–124 (2008)
Sharpe, H. J., Stevens, T. J. & Munro, S. A comprehensive comparison of transmembrane domains reveals organelle-specific properties. Cell 142, 158–169 (2010)
Banfield, D. K. Mechanisms of protein retention in the Golgi. Cold Spring Harb. Perspect. Biol. 3, a005264 (2011)
Wong, M. & Munro, S. Membrane trafficking. The specificity of vesicle traffic to the Golgi is encoded in the golgin coiled-coil proteins. Science 346, 1256898 (2014)
Gao, X. D., Nishikawa, A. & Dean, N. Identification of a conserved motif in the yeast Golgi GDP-mannose transporter required for binding to nucleotide sugar. J. Biol. Chem. 276, 4424–4432 (2001)
Puglielli, L. & Hirschberg, C. B. Reconstitution, identification, and purification of the rat liver Golgi membrane GDP-fucose transporter. J. Biol. Chem. 274, 35596–35600 (1999)
Jardetzky, O. Simple allosteric model for membrane pumps. Nature 211, 969–970 (1966)
Drew, D. & Boudker, O. Shared molecular mechanisms of membrane transporters. Annu. Rev. Biochem. 85, 543–572 (2016)
Forrest, L. R., Krämer, R. & Ziegler, C. The structural basis of secondary active transport mechanisms. Biochim. Biophys. Acta 1807, 167–188 (2011)
Parker, J. L. & Newstead, S. Method to increase the yield of eukaryotic membrane protein expression in Saccharomyces cerevisiae for structural and functional studies. Protein Sci. 23, 1309–1314 (2014)
Drew, D. et al. GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae. Nat. Protoc. 3, 784–798 (2008)
Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protoc. 4, 706–731 (2009)
Winter, G., Lobley, C. M. C. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D 69, 1260–1273 (2013)
Kabsch, W. XDS. Acta Crystallogr. D 66, 125–132 (2010)
Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D 69, 1204–1214 (2013)
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010)
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010)
Blanc, E. et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr. D 60, 2210–2221 (2004)
Eckhardt, M., Gotza, B. & Gerardy-Schahn, R. Mutants of the CMP-sialic acid transporter causing the Lec2 phenotype. J. Biol. Chem. 273, 20189–20195 (1998)
Chan, K. F., Zhang, P. & Song, Z. Identification of essential amino acid residues in the hydrophilic loop regions of the CMP-sialic acid transporter and UDP-galactose transporter. Glycobiology 20, 689–701 (2010)
Stamm, M., Staritzbichler, R., Khafizov, K. & Forrest, L. R. AlignMe—a membrane protein sequence alignment web server. Nucleic Acids Res. 42, W246–W251 (2014)
We thank the staff of beamlines I24 Diamond Light Source, UK, Proxima-2a, Soleil, France and BL1-A, Photon Factory, Japan for assistance. We thank O. Nureki and R. Ishitani for assistance in accessing BL1-A and G. Kuteyi for technical support. This work was supported by Wellcome awards (102890/Z/13/Z and 102890/Z/13/A).
The authors declare no competing financial interests.
Reviewer Information Nature thanks M. Wild, J. Zimmer and the other anonymous reviewer(s) for their contribution to the peer review of this work.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Figure 1 Analysis of anomalous difference electron density and substrate specificity and recognition by Vrg4.
a, Anomalous difference peaks for the mercury (orange mesh) and sulfur (green mesh) atoms calculated using AnoDe and contoured at 3σ, and overlaid on the structure of Vrg4. b, Final refined 2mFo − DFc maps for Vrg4, contoured at 1σ. TM10 is highlighted along with side-chain density. c, Transport cannot be driven by GTP in the presence or absence of CCCP (C) or valinomycin (v). n = 4 independent experiments, data are mean ± s.d. d, Competition assays demonstrate that GMP and GDP–mannose act as the most effective competitors of transport, but other guanosine-containing substrates (GDP, GDP–fucose, GDP–glucose) can also compete and be recognized by the binding site. However, the free base guanosine is very poorly recognized, as is cGMP. Pyrophosphate, which consists of a diphosphate moiety and is an inhibitor of ATPases, cannot inhibit the transport activity of Vrg4. n = 4 independent experiments, data are mean ± s.d.
a, The eight molecules in the P1 unit cell are shown, four of which adopt a dimer arrangement with the monomers arranged in a physiological orientation. Several lipid molecules could be identified and are shown in blue. b, Zoomed-in view of the Vrg4 dimer showing the electrostatic surface of the dimer interface between helices 5 and 10 and the two monoolein lipids bound. The hydrophobic belt is noticeably shorter (~30 Å) than that observed for plasma or inner membrane transporters (~40 Å). Within the dimer interface, the two well-ordered monoolein molecules contribute ~60% to the total buried surface area of 1,514 Å2. In the remaining four monomeric molecules in the unit cell we do not observe any density for lipid molecules at these sites, suggesting an important role for lipid-mediated dimerization. c, Refined 2mFo − DFc electron density for the lipid molecules shown in b, present in the apo crystal structure. d, The dimer-interface lipids were more ordered in the GDP–mannose soaked crystals. All electron density maps are contoured at 1σ.
a, Representative IC50 curves calculated for wild-type Vrg4. ‘GDP–M in’ denotes GDP–mannose-loaded liposomes; ‘GMP in’ denotes GMP-loaded liposomes. b, Calculated IC50 values are the mean of three independent experiments, errors shown are s.d. c, Calculated IC50 values for Fig. 2a, c. n = 3 independent experiments, data are mean ± s.d. d, Calculated IC50 values for Fig. 3c. n = 3 independent experiments, data are mean ± s.d.
a, Crystal structure of Vrg4 bound to GDP–mannose in the plane of the membrane. GDP–mannose is shown as sticks with refined 2mFo − DFc electron density contoured at 1σ. b, Zoomed-in view of the binding site showing key polar interactions. c, Stereo view of bound GDP–mannose shown in b.
Amino acid alignment of S. cerevisiae Vrg4 with GDP–mannose transporters from various organisms (_GMT or _NST) or GDP–fucose transporters (SLC35C1). Identical residues are highlighted in red. The nucleotide-binding, FYNN, and sugar-recognition motifs are indicated as sequence logos. The positions of the 10 transmembrane domains are indicated and coloured from blue to red as in the crystal structure representation of Vrg4 shown on the bottom right.
a, Representative IC50 curves calculated for wild-type Vrg4 (WT) and Tyr114Phe (Y114F) for GMP and GDP–mannose. b, Bar chart showing the IC50 values calculated from a. n = 3 independent experiments, data are mean ± s.d. Wild-type Vrg4 recognizes both GMP and GDP–mannose with the same affinity. Mutating Tyr114 to phenylalanine reduced the affinity for both substrates, demonstrating the importance of the hydroxyl group on this residue for high-affinity binding. Unlike wild-type Vrg4, the Tyr114Phe mutant now recognizes GDP–mannose with a reduced affinity compared to GMP, supporting the interaction we observed in the crystal structure (Fig. 3a).
Extended Data Figure 7 Homology models of the human GDP–fucose transporter (SLC35C1) and CMP–sialic acid transporter (SLC35A1) conserved sequence features across the SLC35 family.
a, View of the binding of Vrg4 with bound GDP–mannose (grey) overlaid with the equivalent residues from the GDP–fucose homology model (blue). Residue numbers are shown first for Vrg4, then for the equivalent residue in the human transporter. The consensus motifs for mannose (GALNK) and fucose (GTAKA) binding are shown, as is the FYNN motif that dictates guanine binding. b, The equivalent analysis was carried out for the human CMP–sialic acid transporter (SLC35A1) which is shown in yellow. Our homology model reveals important insights into the human CMP–sialic acid transporter (CST), which is mutated in the congenital disorder of glycosylation IIf and results in a lack of sialic acid on the surface of cells5. The model of SLC35A1 reveals that the nucleotide-binding pocket has changed from the FYNN motif to the NIQM motif, and now contains a glutamine (Gln212) instead of the asparagine. The extension of the glutamine side chain over the asparagine may help to facilitate the recognition of cytosine, which is smaller than guanine. Previous studies have identified Tyr214 as being important for ligand recognition in the CST40. In our model, this residue faces the membrane and probably anchors Glu212 to stabilize its interaction with the cytosine. Another important difference between the CST and Vrg4 is the replacement of Tyr28 and Tyr281 with lysine side chains (Lys13 and Lys272). Indeed, the mutation of Lys272 results in complete inactivation of CST41. The GALNK motif, by contrast, is replaced by a stretch of alanine side chains. These changes suggest that the binding site is both larger and more positively charged than Vrg4, which would be required to accommodate the nine-carbon sialic acid sugar group; unlike fucose or mannose, it contains an N-acetyl extension at the C5 position in addition to an extended hydroxyl arm at C6.
a, Vrg4 contains two structural repeat units consisting of TM1–TM5 and TM6–TM10, which are related to each other via a two-fold rotation in the plane of the membrane. b, AlignMe42 sequence alignment between the two structural repeats reveals a high degree of sequence conservation, making repeat-swap modelling more accurate. Highlighted in magenta are the equivalent residues in each repeat that form polar interactions in the crystal structure. c, The two repeats align with a root mean square deviation of 5 Å, with the most notable deviation being between helices 4 and 9 and helices 1 and 6, which deviate from each other by 20° and 30°, respectively. It is notable that the axis on which these repeats deviate is where the residues highlighted in magenta overlap. d, The repeat-swapped model of Vrg4 in the open-to-cytoplasm state, which is achieved via a rotation of the structural repeats around an axis that runs through the residues highlighted in magenta.
a, Representative gel filtration trace of the purified Vrg4 in the detergent decylmaltoside which was used for reconstitution, n = 20. The protein elutes as a single peak and is purified to homogeneity as judged by Coomassie-stained SDS–PAGE, in which it runs as a single band at ~30 kDa. b, Size-exclusion chromatography with multi-angle static light scattering analysis indicates that Vrg4 is monomeric in decylmaltoside with an expected mass of 37 kDa (the refractive index increment (dn/dc) values for protein and decylmaltoside detergent used were 0.185 and 0.147, respectively). n = 3 independent experiments, producing similar results. c, Representative SDS–PAGE gel showing reconstitution of Vrg4 into different lipid environments. The same amount of protein was used for each lipid type tested: YPL, POPE:POPG (in a 3:1 ratio), soy PE:egg PG (in a 3:1 ratio), POPE:POPG and POPC (a 3:1 ratio of POPE:POPG with 12% POPC added), POPE:POPG and DMPC (a 3:1 ratio of POPE:POPG with 12% DMPC added). n = 5 independent experiments, producing similar results. The asterisk shows the presence of a protein band (a dimer in size) observed upon reconstitution into liposomes, which is not seen when the protein is in detergent (a, inset) but is observed in the unit cell of the crystal structure. d, Representative gel-filtration profiles of all the mutants used in this study, n = 2 independent experiments, producing similar results. The traces show that all mutant variants behave similarly to wild-type protein during purification, showing monodisperse peaks with little aggregation. With relation to the differing amounts of protein shown in these graphs, this is owing to the different volumes used to express the protein (either >10 l for the upper two panels or 5 l for the lower panel). e, Representative SDS–PAGE gel showing reconstitution of Vrg4 and the mutant variants used in this study, showing that the same amount of protein was used in the assays. n = 3 independent experiments, producing similar results.
About this article
Cite this article
Parker, J., Newstead, S. Structural basis of nucleotide sugar transport across the Golgi membrane. Nature 551, 521–524 (2017). https://doi.org/10.1038/nature24464
Nature Reviews Drug Discovery (2021)
Current Molecular Biology Reports (2021)
Nature Communications (2020)
Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter
Scientific Reports (2020)
Combining native and ‘omics’ mass spectrometry to identify endogenous ligands bound to membrane proteins
Nature Methods (2020)